FOXO3 and nasopharyngeal carcinoma: Consistent with a role for FOXO3 in Lapatinib action in NPC cells, we found that FOXM1 expression is repressed by Lapatinib in the sensitive cells but remains constitutively high in the resistant NPC cells, suggesting a role of FOXM1 in NPC Lapatinib resistance.